Thad Allen Huston

Chief Financial Officer, LivaNova.

Companies

Artiva Biotherapeutics, Inc.Chief financial officer Feb 24, 2026 to now¹
LivaNovaChief financial officer May 22, 2017 to May 27, 2020²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Artiva Biotherapeutics, Inc. ARTV220,000 shares³$1.3M at $5.89Mar 10, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Mar 10, 2026Granted 220,000 shares of Artiva Biotherapeutics, Inc.³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARArtiva Biotherapeutics, Inc., Chief financial officer
2
SEC EDGARLivaNova, Chief financial officer
3
SEC EDGARArtiva Biotherapeutics, Inc. shares after the filing of Mar 10, 2026